Clinical trial
A Study to Evaluate Ezetimibe in Korean Patients With Primary…
NCT00157911 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00157911 |
|---|---|
| Title | A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042) |
| Official title | A Double-Blind, Randomized, Multicenter, Active-Comparative, 12-Week Study to Assess the Efficacy and Safety of the Drug in Conjunction With Another Drug in Korean Patients With Primary Hypercholesterolemia |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholerolemia |
| Intervention type | Drug |
| Interventions | MK0653, ezetimibe / Duration of Treatment: 12 weeks, Comparator: simvastatin / Duration of Treatment: 12 weeks |
| Enrollment | 136 |
| Start date | Dec 1, 2002 |
| Primary completion | Oct 1, 2003 |
| Completion | Dec 1, 2003 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: